Pharmabiz1h
US FDA approves Ionis Pharma’s Tryngolza to treat adults living with familial chylomicronemia syndrome as an adjunct to diet
US FDA approves Ionis Pharma’s Tryngolza to treat adults living with familial chylomicronemia syndrome as an adjunct to diet: Carlsbad, California Monday, December 23, 2024, 15: ...
Pharmabiz1h
GangaGen secures additional US$ 7.9 million from CARB-X for pre-clinical development multidrug-resistant Klebsiella pneumoniae
GangaGen secures additional US$ 7.9 million from CARB-X for pre-clinical development multidrug-resistant Klebsiella pneumoniae: Our Bureau, Bengaluru Monday, December 23, 2024, 14 ...
Pharmabiz2h
Vittoria Biotherapeutics doses first patient in phase 1 clinical trial of VIPER-101
Vittoria Biotherapeutics doses first patient in phase 1 clinical trial of VIPER-101: Philadelphia Monday, December 23, 2024, 13:00 Hrs [IST] Vittoria Biotherapeutics, Inc, a clini ...
Pharmabiz3h
Zealand Pharma’s NDA for glepaglutide gets US FDA complete response letter for treatment of short bowel syndrome
Zealand Pharma A/S, a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced that the US Food and Drug Administration (FDA) has issued a ...
Pharmabiz4h
Myriad Genetics’ RiskScore named one of the top 10 significant advances in genomic medicine
Myriad Genetics’ RiskScore named one of the top 10 significant advances in genomic medicine: Salt Lake City Monday, December 23, 2024, 11:00 Hrs [IST] Myriad Genetics, Inc, a le ...
Pharmabiz4h
Session on diagnosis and treatment illuminates latest advances in migraine diagnosis and treatment
Session on diagnosis and treatment illuminates latest advances in migraine diagnosis and treatment: Our Bureau, Mumbai Monday, December 23, 2024, 11:30 Hrs [IST] In a landmark eve ...
Pharmabiz6h
Valneva signs exclusive license agreement with Serum Institute of India for its single-shot chikungunya vaccine to supply in Asia
Saint-Herblain, France Monday, December 23, 2024, 09:00 Hrs [IST] ...
Pharmabiz8h
FOPE calls for inclusion of temperature, humidity & photosensitive drugs under Schedule P of D&C Rules
Nandita Vijayasimha, Bengaluru Monday, December 23, 2024, 08:00 Hrs [IST] ...
Pharmabiz5h
Pfizer’s BRAFTOVI combination regimen receives US FDA approval for treatment of metastatic colorectal cancer
Pfizer’s BRAFTOVI combination regimen receives US FDA approval for treatment of metastatic colorectal cancer: New York Monday, December 23, 2024, 10:00 Hrs [IST] Pfizer Inc anno ...
Pharmabiz8h
FSSAI clarifies regulations on Methylcobalamin usage in health supplements and for medical purposes
FSSAI clarifies regulations on Methylcobalamin usage in health supplements and for medical purposes: Shardul Nautiyal, Mumbai Monday, December 23, 2024, 08:00 Hrs [IST] The Food S ...
Pharmabiz8h
GCCs synergize AI and data analytics to address challenges of modern healthcare
GCCs synergize AI and data analytics to address challenges of modern healthcare: Monday, December 23, 2024, 08:00 Hrs [IST] Global Capability Centres (GCCs) play a pivotal role to ...
Pharmabiz8h
Parliamentary panel asks DoP to act fast on spurious drug cases
Parliamentary panel asks DoP to act fast on spurious drug cases: Gireesh Babu, New Delhi Monday, December 23, 2024, 08:00 Hrs [IST] The Parliamentary Panel that looked into the op ...